McKesson Corporation Stock News

Healthcare stocks have been trailing the market this year. Vanguard's Health Care ETF (NYSEARCA: VHT ) is down 5% on the year, compared with a 10% year-to-date gain in the benchmark S&P 500 index.

Pfizer's priorities include investing in its business and rewarding shareholders through dividend growth. McKesson has shifted its focus to its highest-growth and highest-margin businesses.

Consumers will spend in almost any economy; you just have to offer what they want or need most. IBM may never become the tech powerhouse it once was, but it reliably generates cash.

McKesson Corp. NYSE: MCK is among the elite group of stocks breaking out of bases and approaching new highs. While there have been numerous breakouts recently, many are out of patterns forming well be

McKesson's (MCK) fiscal fourth-quarter 2023 results benefit from growth in the United States. Divestment hurt the International segment.

Mastercard and McKesson both have solid growth profiles. They both have increased their dividend payouts.

McKesson Corporation (NYSE:MCK ) Q4 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Nicole Kramer - Manager, Investor Relations Brian Tyler - Chief Executive Officer Britt Vi

The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimate

McKesson's (MCK) fiscal fourth-quarter results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.

Demand for Moderna's COVID-19 vaccine will taper off this year, but investors remain bullish on its prospects. McKesson is a top distributor of pharmaceuticals and a key cog in the healthcare industry

Pfizer is early in what should be a busy 18-month period for new treatments and label expansions, with as many as 19 possible by midyear 2024. McKesson should benefit from its focus on two high-growth

Healthcare stocks are one of the best bets out there. The U.S. spends more on healthcare than any other country.

McKesson is shifting its focus into its highest growth areas: oncology and biopharma services. The company also plans on rewarding investors through dividends and share buybacks.

Holding stocks that consistently grow a bit every year without fail is a good idea. McKesson will continue to grow for as long as the healthcare sector does.

Viking Global Investors is an elite hedge fund run by former Tiger Cub Andreas Halvorsen. The Norwegian billionaire has a nearly unparalleled track record of success in the often fickle stock-picking